Heart Failure

January 20, 2021

The US FDA has approved vericiguat (Verquvo) for reducing the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient intravenous diuretics in patients with HFrEF.

January 19, 2021

A meta-analysis of nearly 20 studies is offering clinicians further insight into the effects of consuming fried foods on cardiovascular health.

January 12, 2021

A retrospective cohort study suggests peak atrial longitudinal strain and peak atrial contraction strain could help clinicians identify HFpEF patients at greatest risk for developing atrial fibrillation.

January 09, 2021

An analysis of data from a medical center in the UK suggests patients with heart failure were at nearly double the risk of dying from COVID-19 as their counterparts without COVID-19.

January 06, 2021

An analysis of more than 1000 matched pairs of women receiving one of two common treatments for breast cancer were half as likely to be hospitalized for heart failure if they were also using statins.

January 05, 2021

Gregory Weiss, MD, offers perspective on the diagnosis and management of heart failure during 2020.

December 24, 2020

This article features the top 5 stories in Practical Cardiology's coverage of heart failure in 2020.

November 24, 2020

An analysis of data from the Women's Health Initiative details the detrimental impact of sedentary behavior on the risk of heart failure in older women.

November 18, 2020

TRANSLATE-HF is a collaborative effort between the AHA and AstraZeneca with the goal of increasing and optimizing SGLT2 inhibitor use in US patients. Hear further insight lead author from the first of 6 TRANSLATE-HF studies, which was presented at AHA 2020.

November 17, 2020

Deepak Bhatt, MD, MPH, offers his thoughts on the results of SCORED and SOLOIST as well as diving deeper into the implications of the data for sotagliflozin and SGLT2 inhibitors moving forward.